- Home
- ELDN vs ANIK Comparison
ELDN vs ANIK Comparison
Compare ELDN & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- ANIK
- Stock Information
- Founded
- ELDN 2004
- ANIK 1983
- Country
- ELDN United States
- ANIK United States
- Employees
- ELDN N/A
- ANIK N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- ANIK Medical/Dental Instruments
- Sector
- ELDN Health Care
- ANIK Health Care
- Exchange
- ELDN Nasdaq
- ANIK Nasdaq
- Market Cap
- ELDN 164.1M
- ANIK 133.1M
- IPO Year
- ELDN N/A
- ANIK 1993
- Fundamental
- Price
- ELDN $3.50
- ANIK $9.67
- Analyst Decision
- ELDN Strong Buy
- ANIK Buy
- Analyst Count
- ELDN 2
- ANIK 1
- Target Price
- ELDN $12.50
- ANIK $15.00
- AVG Volume (30 Days)
- ELDN 1.4M
- ANIK 100.1K
- Earning Date
- ELDN 11-11-2025
- ANIK 10-31-2025
- Dividend Yield
- ELDN N/A
- ANIK N/A
- EPS Growth
- ELDN N/A
- ANIK N/A
- EPS
- ELDN 0.21
- ANIK N/A
- Revenue
- ELDN N/A
- ANIK $114,548,000.00
- Revenue This Year
- ELDN N/A
- ANIK N/A
- Revenue Next Year
- ELDN N/A
- ANIK $4.57
- P/E Ratio
- ELDN $16.22
- ANIK N/A
- Revenue Growth
- ELDN N/A
- ANIK 16.52
- 52 Week Low
- ELDN $2.32
- ANIK $7.87
- 52 Week High
- ELDN $5.54
- ANIK $25.44
- Technical
- Relative Strength Index (RSI)
- ELDN 70.99
- ANIK 60.52
- Support Level
- ELDN $2.58
- ANIK $8.67
- Resistance Level
- ELDN $2.71
- ANIK $9.26
- Average True Range (ATR)
- ELDN 0.24
- ANIK 0.34
- MACD
- ELDN 0.07
- ANIK 0.03
- Stochastic Oscillator
- ELDN 72.69
- ANIK 98.93
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.